AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for a Phase 1 B clinical trial investigating the Company`s ROOT OF CANCER technology in patients with metastatic melanoma. AIVITA`s ROOT OF CANCER...
California, January 19: After Apple, Google' s parent company Alphabet is working its way towards bringing health at the center of its products. Now, the company's health division Verily has reportedly received FDA 510 clearance for its Study smartwatch for an on-demand ECG feature. The feature is increasingly becoming a standard for a lot of manuf
Albany, NY 01/19/2019 The global Antibody Drug Conjugates Market are very effective biopharmaceuticals developed as the targeted therapeutic helpful in the treatment of Cancer. Antibody drugs conjugates are further designed to eradicate the cancer cells without harming the normal cells. Of these, Adcertis drug segment dominate this market due
"Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on the gamut of sectors across the globe" The aging workforce in laboratory tests, the growing demand for high quality laboratory services and the growing need for fast results will lead to the expansion of the global market fo
Rockville, MD 01/19/2019 Bee pollen is a mixture of pollens picked by bees, bee saliva, and some nectar. Bee pollen Supplements have been popular for its high nutrient content and medicinal properties. German Federal Board of Health has recognized bee pollen supplements as medicine, owing to its medicinal benefits.
Jones Lang LaSalle issued the following news release:. Small and mid-tier companies are responsible for 63 percent of new products brought to market since 2013, according to HBM Partners, making 2019 the year for Big Pharma to add more innovation to its business model. "Without productive, efficient R&D processes that deliver strong revenues to dr
Albany, NY 01/19/2019 Biosimilars are drugs that are highly similar but not identical to branded innovator biologics: large molecule, immunogenic drugs produced from living cells. Innovator biologics are the first to be approved, and when their patent protection expires, biosimilars may be approved, in a similar way to small molecule branded
Waltham-based AMAG Pharmaceuticals said it has completed a previously announced acquisition of Perosphere Pharmaceuticals, a private biopharmaceutical company. Through this acquisition, AMAG adds ciraparantag to its development portfolio. Ciraparantag has been granted fast track review designation by the U.S. Food and Drug Administration and has...
The American Society of Clinical Oncology, Friends of Cancer Research, and the US Food and Drug Administration recently recommended modernizing criteria related to comorbidities routinely used to exclude patients from cancer clinical trials. The goal was to design clinical trial eligibility such that trial results better reflect real-world cancer..
Albany, NY 01/19/2019 Transparency Market Research has published a new report titled, "Contact Lens Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 2026". According to the report, the global contact lens market was valued at US$ 11,155.7 Mn in 2017 and is anticipated to expand at a CAGR of 7.4% during fore
The Cystinosis Research Foundation, the largest provider of grants for cystinosis research in the world, today announced that the Federal Drug Administration granted approval for the first human clinical trial for stem cell and gene therapy treatment for cystinosis. Over the last 12 years, CRF has provided more than $4.3 million in research funding
By Jun Ji- hye The ongoing US government shutdown has left Korean drug companies hanging, including Daewoong Pharmaceutical and SK Biopharmaceuticals, as the closed Food and Drug Administration has been unable to review and approve medicines. Daewoong Pharmaceutical has been waiting for FDA approval for its botulinum toxin product, called Nabota Th
Albany, NY 01/19/2019 Transparency Market Research has published a new report titled " Drug Delivery System Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 2025". Key players introduce new drugs delivery systems and devices in developed markets such a North America and Western Europe. Rise in R&D investmen
Albany, NY 01/19/2019 The hemophilia treatment drugs market is likely to slate robust growth with surged investments towards healthcare infrastructure globally. Further, emergence of novel coagulating factors as well as rising prevalence of hemophilia are other potential growth catalysts in global hemophilia treatment drugs market.
Albany, NY 01/19/2019 Transparency Market Research has published a new report titled, "Head and Neck Cancer Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 2026". According to the report, the global head and neck cancer market was valued at US$ 933.3 Mn in 2017 and is anticipated expand at a CAGR of 9.2% f
The University of Science and Technology issued the following news release:. -Researchers from The Hong Kong University of Science and Technology credited with important translational science and early discovery work. SAN DIEGO AND HONG KONG- aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicin
Jan. 19 A physician pleaded guilty Friday in U.S. District Court in New Haven to a count of conspiracy to commit health care fraud in an alleged scheme with her husband to defraud Connecticut's state-employee prescription benefit plan, as well as other government health programs, by submitting prescriptions for very expensive "compound medicati
-Kitov Pharma Ltd., an innovative pharmaceutical company, today announced the closing of its previously announced registered direct offering of 3,428,572 American Depositary Shares at a purchase price of $1.75 per ADS, for gross proceeds of $6 million. Copies of the final prospectus supplement and the accompanying prospectus relating to the registe
-Kura Oncology, Inc., a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, reported new findings identifying a potential association between CXCL12 expression and clinical benefit in patients with pancreatic cancer treated with tipifarnib. These findings are being presented today at the 2019...
The Sackler family came under heavy scrutiny this week when a legal filing in a Massachusetts case asserted that family members and company executives sought to push prescriptions of the drug and downplay its risks. Members of the family that controls Connecticut- based Purdue Pharma are also defendants in a lawsuit brought by New York's Suffolk Co
Luye Pharma has entered an agreement with AstraZeneca China, the terms of which grant AstraZeneca China exclusive rights to promote Luye Pharma`s Xuezhikang Capsules in mainland China. This is the first time that a multinational pharmaceutical company has gained exclusive authorization in China to promote an innovative drug independently developed
-The Icahn School of Medicine at Mount Sinai has entered into two exclusive licenses to develop the drug pentosan polysulfate sodium for the treatment of mucopolysaccharidosis, with Australia- based company Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. of Japan. Calogera Simonaro, PhD, Research Professor in the Department of Genetics an
The Ichan School of Medicine at Mount Sinai issued the following news release:. The Icahn School of Medicine at Mount Sinai has entered into two exclusive licenses to develop the drug pentosan polysulfate sodium for the treatment of mucopolysaccharidosis, with Australia- based company Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. of Jap
Although prescription opioids are involved in more than one-third of all opioid overdose deaths in the United States, examining any correlation between prescription opioid overdose deaths and pharmaceutical industry marketing has been limiteduntil now. New research from NYU School of Medicine and Boston Medical Center published online January 18.